Smartkem, INC

SmartKem, Inc. announced a definitive agreement to combine with Ferrox Critical Minerals, Ltd. in an all-stock transaction valued at approximately $125 million, aiming for vertical integration.

SmartKem, Inc. has provided a $4.9 million convertible promissory note to Ferrox Critical Minerals, detailing terms for potential equity conversion and outlining significant covenants.

SmartKem, Inc. stockholders have approved a significant increase in authorized shares to 5 billion and granted authority for two reverse stock splits.

SmartKem, Inc. announced that its wholly owned subsidiary, SmartKem, Ltd., has initiated a creditors' voluntary liquidation process.

SmartKem, Inc. has been notified by the Nasdaq Hearings Panel that it has regained compliance with the stockholders equity requirement and other listing criteria, though it remains subject to a bid price grace period and panel monitoring.

SmartKem, Inc. filed an amendment to its Form 8-K, correcting specific details regarding its Series A Preferred Stock financing and associated warrants.

SmartKem reports a net loss of $19.4 million for Q1 2026, driven by significant non-operating expenses related to financing activities and ongoing capital requirements.

SmartKem, Inc. reported increased losses and a critical cash shortage, leading to a non-binding merger agreement with Jericho Energy Ventures and a bridge financing loan.

SmartKem, Inc. reported significant losses and a dwindling cash balance, raising substantial doubt about its ability to continue as a going concern, despite a new lease agreement and increased operating income.

SmartKem reports a net loss of $2.134 million for Q1 2025 and expresses substantial doubt about its ability to continue as a going concern without additional funding.

SmartKem's Q3 2024 results reveal ongoing losses and a need for additional funding, raising concerns about the company's ability to continue as a going concern.

SmartKem's Q2 2024 results show a net loss of $4.8 million and highlight the company's need for additional funding to continue operations.

SmartKem's 2024 annual report highlights continued losses and a strategic focus on commercializing its TRUFLEX technology, particularly for MicroLED displays.

SmartKem's 10-K filing details the company's capital structure, including common and preferred stock, voting rights, and anti-takeover provisions.

SmartKem Director Joseph Christopher Lizzio reported gifting 150,000 shares of common stock, reducing his direct beneficial ownership to 419,000 shares.

SmartKem, Inc. Director Steven Denbaars was granted 22,466 stock options with an exercise price of $1.16, vesting over 36 months.

SmartKem Director Melisa Denis was granted 22,466 stock options with an exercise price of $1.16, vesting over 36 months.

SmartKem Director Klaas de Boer was granted 22,466 stock options with an exercise price of $1.16, vesting over 36 months.

SmartKem's Chairman and CEO, Ian Jenks, was granted 160,005 stock options with an exercise price of $1.16, vesting over 36 months.

SmartKem's Chief Financial Officer, Barbra Keck, was granted 71,077 stock options with an exercise price of $1.16, vesting over a 36-month period.

SmartKem, Inc. has issued a proxy statement for its 2026 Annual Meeting, seeking shareholder approval for significant capital structure changes, including a massive increase in authorized shares and reverse stock split authority.

SmartKem, Inc. is holding its annual stockholder meeting on May 28, 2025, to vote on key proposals including the election of a director, ratification of the company's accounting firm, and an amendment to the 2021 Equity Incentive Plan.

SmartKem, Inc. will hold its Annual Meeting of Stockholders virtually on September 23, 2024, to elect directors and ratify the appointment of its independent registered public accounting firm.

SmartKem, Inc. has filed a registration statement for the potential resale of up to 146.78 million shares of common stock in connection with a $500 million committed equity financing agreement with Keystone Capital Partners.

SmartKem, Inc. files an amendment to its Form S-1 registration statement to include an updated exhibit related to auditor consent.

SmartKem, Inc. has filed an amendment to its Form S-1 registration statement with the SEC, pertaining to the sale of up to 6,402,818 shares of common stock by selling stockholders.

SmartKem, Inc. has filed a registration statement for the resale of up to 6,402,818 shares of its common stock by selling stockholders.

SmartKem, Inc. has filed a registration statement for the resale of up to 1,567,599 shares of its common stock by selling stockholders, stemming from the exercise of Class B and Class C warrants.

Octopus Investments and Octopus Titan VCT Plc's beneficial ownership in SmartKem, Inc. has decreased to 4.8% due to the conversion of SmartKem's Series A-1 Preferred Stock into common shares and warrants, not through any sale by Octopus.

Octopus Investments Limited and Octopus Titan VCT Plc have updated their beneficial ownership in SmartKem, Inc. to 6.0% and 5.9% respectively, a decrease primarily due to a reverse stock split, a preferred stock conversion, and private placement offerings by the issuer.

Joseph Christopher Lizzio files an amendment to Schedule 13G, reporting beneficial ownership of 419,000 shares of SmartKem, Inc. common stock.

AIGH Capital Management and related entities report beneficial ownership of 4.9% of SmartKem, Inc. common stock, primarily through exercisable warrants.

AIGH Capital Management LLC and Orin Hirschman have jointly filed an Amendment No. 5 to Schedule 13G, reporting beneficial ownership of 9.9% of SmartKem, Inc.'s Common Stock.

Five Narrow Lane LP has filed an Amendment No. 2 to Schedule 13G, reporting a 4.69% beneficial ownership stake in SMARTKEM INC. as of December 31, 2025.

Bleichroeder LP, Bleichroeder Holdings LLC, and Andrew Gundlach have reported a 4.1% beneficial ownership stake in SmartKem, Inc. as of September 30, 2025.

Five Narrow Lane LP has reported an increased beneficial ownership in Smartkem Inc. to 7.49% of common stock, subject to a 4.99% control restriction.